Marlborough-based API Technologies Corp. has sold its electronics manufacturing services business, API Defense USA, to Norwegian manufacturing firm Kitron for $14.8 million. The business was located ...
EAST RUTHERFORD, N.J., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), ...
EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...
TIANJIN, China, May 31, 2019 /PRNewswire/ -- Asymchem, a leading custom manufacturer of Intermediates and API's for the pharmaceutical industry, today announced that its Dunhua 1 site, a small ...
The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results